The Discounted Cash Flow (DCF) valuation of DaehanPharmaceutical (023910.KQ) is 84,509.83 KRW. With the latest stock price at 27,450.00 KRW, the upside of DaehanPharmaceutical based on DCF is 207.9%.
Based on the latest price of 27,450.00 KRW and our DCF valuation, DaehanPharmaceutical (023910.KQ) is a buy. buying 023910.KQ stocks now will result in a potential gain of 207.9%.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 8.9% | 7.7% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 71,738.67 - 104,890.07 | 84,509.83 |
| Upside | 161.3% - 282.1% | 207.9% |